1 article
GPT-5 Pro independently suggested dupilumab—a drug already approved for eczema and asthma—as a potential treatment for FPIES, a rare food allergy. This matched real clinical findings from Dr. Oral Alpan.
We use cookies to improve your experience on our site and to show you relevant advertising. To find our more, read our privacy policy and cookie policy